The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota
Changes over three decades
Teresa S. M. Tsang, MD, FACC*,*,
George W. Petty, MD ,
Marion E. Barnes, MSc*,
W. Michael O’Fallon, PhD ,
Kent R. Bailey, PhD,
David O. Wiebers, MD ,
JoRean D. Sicks, MS,
Teresa J. H. Christianson, BSc,
James B. Seward, MD, FACC* and
Bernard J. Gersh, MB, ChB, DPhil, FACC*
* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Division of Cerebrovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
Section of Clinical Epidemiology, Mayo Clinic, Rochester, Minnesota, USA
View larger version (39K):
[in a new window]
|
Figure 1 Prevalence of atrial fibrillation in 1,871 patients with ischemic stroke and their age- and gender-matched controls, stratified by age, gender, and calendar decade.
|
|
View larger version (14K):
[in a new window]
|
Figure 2 Trends for age-adjusted prevalence of atrial fibrillation in 1,871 patients with ischemic stroke and their age- and gender-matched controls, stratified by gender. *Significant (p = 0.001) time trend among case patients; insignificant (p = 0.702) difference between men and women. Significant (p < 0.001) time trend among controls; insignificant (p = 0.098) difference between men and women.
|
|
View larger version (31K):
[in a new window]
|
Figure 3 Prevalence of atrial fibrillation (AF) and comorbid conditions in 1,871 patients with ischemic stroke and their age- and gender-matched controls, stratified by calendar decade. CAD = coronary artery disease; CHF = congestive heart failure; CS = cardiac surgery; DM = diabetes mellitus; HTN = hypertension; MI = myocardial infarction; VHD = valvular heart disease.
|
|
|
